Stockscreener 앱 받기
9.98
3.57%
-0.37
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Terry L. Evans Purchases 2,326 Shares Through Fennec Pharmaceuticals ESPP - Kalkine Media
Form 4 FENNEC PHARMACEUTICALS INC.: Jeffrey S. Hackman (Director, CEO) For: 12 October - Investing.com Canada
TRex Bio Files for Nasdaq IPO - Yahoo! Finance Canada
Award shares leave restriction as Fennec Pharmaceuticals (FENC) CFO acquires 1,703 shares. - stocktitan.net
Medical chief acquires 168 awarded shares at Fennec Pharmaceuticals (FENC), holding 9,687 directly. - stocktitan.net
Commercial chief acquires 168 shares released from restriction at Fennec Pharmaceuticals (FENC). - stocktitan.net
1,159 award shares released; Fennec Pharmaceuticals (FENC) CEO directly holds 67,461 shares afterward. - stocktitan.net
After a 156-share award release, Fennec (FENC) strategy chief holds 24,800 shares. - stocktitan.net
FENC 8-K FilingsFennec Pharmaceuticals Inc. SEC 8-K - stocktitan.net
Fennec Pharmaceuticals (FENC) director exercises options, then sells matching shares - Stock Titan
Director at Fennec Pharmaceuticals (NASDAQ: FENC) plans to sell 15,545 shares - Stock Titan
Fennec Pharmaceuticals (NasdaqCM:FENC) Stock Forecast & Analyst Predictions - Simply Wall Street
Why Fennec Pharmaceuticals Inc stock plummeted yesterday - Wealth Awesome
(FENC) Risk Channels and Responsive Allocation - Stock Traders Daily
Fennec Pharmaceuticals Stock Price Forecast. Should You Buy FRX.TO? - StockInvest.us
What's Going On With Fennec Pharmaceuticals Inc Stock Thursday? - Wealth Awesome
Fennec Pharmaceuticals Insider Rosty Raykov Reports Share Vesting and Sale - kalkinemedia.com
Former Fennec (NASDAQ: FENC) director lines up $121K stock sale - Stock Titan
Former Fennec Pharma (NASDAQ: FENC) director sells 10,000 shares under 10b5-1 plan - Stock Titan
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Fennec CCO receives 168 shares at zero cost - Stock Titan
Fennec Pharma CEO gains 1,159-share award - Stock Titan
Fennec Pharma (NASDAQ: FENC) officer to sell 12,000 shares - Stock Titan
156 previously restricted Fennec Pharma (FENC) shares are released to the chief strategy officer at a stated $0.00 per share. - Stock Titan
Fennec (NASDAQ: FENC) CMO sells 12,000 vested shares in an August 31 trade not tied to a preset Rule 10b5-1 plan. - Stock Titan
CFO boosts stake at Fennec Pharmaceuticals (FENC) as 1,703 previously restricted shares are released to him - Stock Titan
Trade Alert: Chief Financial Officer Of Fennec Pharmaceuticals Robert Andrade Has Sold Stock - webull.com
Trade Alert: Chief Financial Officer Of Fennec Pharmaceuticals Robert Andrade Has Sold Stock - simplywall.st
Fennec Pharma (NASDAQ: FENC) CFO sells 75K shares in plan trade - Stock Titan
Fennec Pharma (NASDAQ: FENC) officer to sell 75,000 shares - Stock Titan
What's Going On With Fennec Pharmaceuticals Inc Stock Thursday? - Wealth Awesome
Fennec Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:FENC - TradingView
Fennec (FENC) Results Review: Reported EPS Tops Expectations in the Latest Reading; Share Response: The Share Price Sheds 4.63% at the CloseEPS Estimate Trend - vinanet.vn
Fennec (FENC) Results Check: Profit Per Share Clears Its Benchmark on the Day; Investor Response - vinanet.vn
Fennec (FENC) Technical Check: Adds 0.51% to Close at $11.89 at the Close; Current Setup: the Supplied Trading Band Runs From $11.30 to $12.48Throwback Trade - vinanet.vn
Jessica Vargas Appointed Vice President of Human Resources at Fennec Pharmaceuticals - hrtoday.in
(FENC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Fennec Pharmaceuticals (FENC): Southpoint group files 13G/A showing 0% ownership - Stock Titan
Fennec Pharmaceuticals (FENC) Gets a Buy from Maxim Group - The Globe and Mail
Solas Capital Management (FENC) reports 1.89M Fennec shares, a 5.4% ownership stake - Stock Titan
Results: Fennec Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Moomoo
Results: Fennec Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Results: Fennec Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views - Yahoo Finance
Fennec Pharmaceuticals Announces Q2 2026 Net Income and Revenue Growth - Kalkine Media
Fennec Pharmaceuticals (FENC) Stock Jumps As Profitability Raises A Bigger Question - webull.com
Fennec Pharmaceuticals (FENC) gains 9.6% stakeholder via Rosalind Advisors - Stock Titan
Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush - The Globe and Mail
Why Fennec Pharmaceuticals Inc stock plummeted yesterday - Wealth Awesome
What's Going On With Fennec Pharmaceuticals Inc Stock Thursday? - Wealth Awesome
4.22%
자본화:
|
볼륨(24시간):